Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.107NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.172NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.110NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.320NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.91NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-21388.1US
JN.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.55.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.62NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.55NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.120 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EU.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.17.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.63NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.14.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.13.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used